英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
BRD4097 |
化合物 T30579 |
1550053-19-4 |
詳細(xì)
|
Sanfetrinem |
山費(fèi)培南 |
156769-21-0 |
詳細(xì)
|
PFM03 |
化合物 PFM03 |
1558598-48-3 |
詳細(xì)
|
SB-209670 |
(1S,2R,3S)-1-(1,3-BENZODIOXOL-5-YL)-3-[2-(CARBOXYMETHYLOXY)-4-METHOXYPHENYL]-5-PROPOXY-2,3-DIHYDRO-1H-INDENE-2-CARBOXYLIC ACID |
157659-79-5 |
詳細(xì)
|
Prenyletin |
化合物PRENYLETIN |
15870-91-4 |
詳細(xì)
|
Erythrinin G |
刺桐素 G |
1616592-61-0 |
詳細(xì)
|
Moiramide B |
CB03169878 |
155233-31-1 |
詳細(xì)
|
SDZ 224-015 |
SDZ 224-015 |
161511-45-1 |
詳細(xì)
|
CC-17369 |
CC-17369 |
1547162-46-8 |
詳細(xì)
|
Afasevikumab |
Afasevikumab |
1589503-30-9 |
詳細(xì)
|
Alniditan dihydrochloride |
阿尼地坦 |
155428-00-5 |
詳細(xì)
|
AEF0117 |
AEF0117 |
1610878-71-1 |
詳細(xì)
|
Bectumomab |
貝妥莫單抗 |
158318-63-9 |
詳細(xì)
|
Carbamazepine-d8 |
[2H8]-Carbamazepine |
1538624-35-9 |
詳細(xì)
|
STS-E412 |
化合物 T24840 |
1609980-39-3 |
詳細(xì)
|
Terodiline |
特羅地林 |
15793-40-5 |
詳細(xì)
|
ZEN-2759 |
化合物 ZEN-2759 |
1616400-50-0 |
詳細(xì)
|
Tezepelumab |
Tezepelumab |
1572943-04-4 |
詳細(xì)
|
Prezalumab |
Prezalumab |
1523164-68-2 |
詳細(xì)
|
SRI-41315 |
2-環(huán)丁基-10-甲基-3-苯基嘧啶并[4,5-B]喹啉-4,5(3H,10H)-二酮 |
1613509-49-1 |
詳細(xì)
|
PPT |
化合物 T24654 |
1529779-90-5 |
詳細(xì)
|
(2,2-Dimethyl-1,3-dioxolan-4-yl)methyl 2-(2-((2,6-dichlorophenyl)amino)phenyl)acetate |
(2,2-二甲基-1,3-二氧戊環(huán)-4-基)甲基 2-(2-((2,6-二氯苯基)氨基)苯基)乙酸酯 |
1528769-06-3 |
詳細(xì)
|
BMS 182874 |
化合物 T26841 |
153042-42-3 |
詳細(xì)
|
Antiviral agent 17 |
化合物 ANTIVIRAL AGENT 17 |
158227-81-7 |
詳細(xì)
|
Tesidolumab |
Tesidolumab |
1531594-08-7 |
詳細(xì)
|
Rovalpituzumab |
洛伐妥珠單抗 |
1613313-01-1 |
詳細(xì)
|
Birtamimab |
Birtamimab |
1608108-91-3 |
詳細(xì)
|
Rozanolixizumab |
洛利昔珠單抗 |
1584645-37-3 |
詳細(xì)
|
Ensaculin |
Ensaculin |
155773-59-4 |
詳細(xì)
|
Regavirumab |
瑞加韋單抗 |
153101-26-9 |
詳細(xì)
|
Propanol-PEG4-CH2OH |
丙醇-四聚乙二醇-CH2-羥基 |
156868-17-6 |
詳細(xì)
|
Simmiparib |
SIMMIPARIB |
1551355-46-4 |
詳細(xì)
|
Tenofovir amibufenamide |
艾米替諾福韋 |
1571076-26-0 |
詳細(xì)
|
Ticolubant |
Ticolubant |
154413-61-3 |
詳細(xì)
|
Daclizumab |
達(dá)昔單抗 |
152923-56-3 |
詳細(xì)
|
PDE5-IN-9 |
2-(吡啶-3-基)-N-(噻吩-2-基甲基)喹唑啉-4-胺 |
157862-84-5 |
詳細(xì)
|
Afelimomab |
阿非莫單抗 |
156227-98-4 |
詳細(xì)
|
Galcanezumab |
伽奈珠單抗 |
1578199-75-3 |
詳細(xì)
|
Tyk2-IN-7 |
TYK2-IN-7 (COMPOUND 48) |
1609391-90-3 |
詳細(xì)
|
BNC375 |
BNC375 |
1557240-80-8 |
詳細(xì)
|
Lokivetmab |
Lokivetmab |
1533403-95-0 |
詳細(xì)
|
Rinucumab |
Rinucumab |
1569263-06-4 |
詳細(xì)
|
Brazikumab |
Brazikumab |
1610353-18-8 |
詳細(xì)
|
Antifungal agent 76 |
抗菌劑 76 |
1615683-57-2 |
詳細(xì)
|
Adafosbuvir PM |
化合物ADAFOSBUVIR PM |
1613589-04-0 |
詳細(xì)
|
Cedelizumab |
Immunoglobulin G4,anti-(human CD4 (antigen)) (human-mouse monoclonal OKTcdr4a complementarydetermining region-grafted g4-chain), disulfide with human-mouse monoclonal OKTcdr4a complementarydetermining region-grafted k-chain, dimer (9CI) |
156586-90-2 |
詳細(xì)
|
[6]-Gingerdiol |
6]-Gingerdiol |
154905-69-8 |
詳細(xì)
|
Brolucizumab |
Brolucizumab |
1531589-13-5 |
詳細(xì)
|
Rezvilutamide |
REZVILUTAMIDE |
1572045-62-5 |
詳細(xì)
|
(S)-Enitociclib |
VIP152 |
1610408-97-3 |
詳細(xì)
|
Sel-green |
SEL-GREEN |
1574299-37-8 |
詳細(xì)
|
2-PCCA hydrochloride |
2-PCCA鹽酸鹽 |
1609563-70-3 |
詳細(xì)
|
Branaplam hydrochloride |
布拉撲蘭鹽酸鹽 |
1562338-39-9 |
詳細(xì)
|
(R,1R)-Tenofovir amibufenamide |
化合物 (R,1R)-TENOFOVIR AMIBUFENAMIDE |
1571076-37-3 |
詳細(xì)
|
Cholesterol 24-hydroxylase-IN-1 |
化合物 CHOLESTEROL 24-HYDROXYLASE-IN-1 |
1613480-70-8 |
詳細(xì)
|
Casein kinase 1δ-IN-6 |
酪蛋白激酶1Δ-IN6 |
1579991-01-7 |
詳細(xì)
|
isomer-CM 352 |
CM 352異構(gòu)體 |
1542205-84-4 |
詳細(xì)
|
Finrozole |
芬羅唑 |
160146-17-8 |
詳細(xì)
|
DF-1111301 |
DF-1111301 |
160665-99-6 |
詳細(xì)
|
Darigabat |
PF-06372865 |
1614245-70-3 |
詳細(xì)
|
Baihuaqianhuoside |
BAIHUAQIANHUOSIDE |
155969-61-2 |
詳細(xì)
|
BPI-9016M |
BPI-9016M |
1528546-94-2 |
詳細(xì)
|
Icotinib-d4 |
??颂婺酓4 |
1567366-82-8 |
詳細(xì)
|
Plozalizumab |
Plozalizumab |
1610761-46-0 |
詳細(xì)
|
Satralizumab |
薩特利珠單抗 |
1535963-91-7 |
詳細(xì)
|
Blontuvetmab |
Blontuvetmab |
1608112-78-2 |
詳細(xì)
|
N-Desethyl Chloroquine Hydrochloride |
Hydroxychloroquine Sulfate EP Impurity D DiHCl (Desethyl Chloroquine DiHCl) |
15912-96-6 |
詳細(xì)
|
Solpecainol |
索培卡諾 |
155321-96-3 |
詳細(xì)
|
PKH 26 |
PKH-26 (RED) 外泌體示蹤染料 |
154214-55-8 |
詳細(xì)
|
Odulimomab |
奧度莫單抗 |
159445-64-4 |
詳細(xì)
|
Linetastine |
利奈他斯汀 |
159776-68-8 |
詳細(xì)
|
Levonadifloxacin |
左氧那地沙星 |
154357-42-3 |
詳細(xì)
|
Antimalarial agent 30 |
抗瘧劑 30 |
1597425-64-3 |
詳細(xì)
|
PF-06256142 |
化合物 T12423 |
1609583-14-3 |
詳細(xì)
|
Varisacumab |
Varisacumab |
1610010-60-0 |
詳細(xì)
|
(R)-Enitociclib |
化合物 (R)-ENITOCICLIB |
1610408-96-2 |
詳細(xì)
|
DFHBI-2T |
DFHBI-2T |
1539318-40-5 |
詳細(xì)
|
Amredobresib |
AMREDOBRESIB |
1610044-98-8 |
詳細(xì)
|
Inolimomab |
伊諾莫單抗 |
152981-31-2 |
詳細(xì)
|
Edrecolomab |
依決洛單抗 |
156586-89-9 |
詳細(xì)
|
Carboxyebselen |
CARBOXYEBSELEN |
153871-75-1 |
詳細(xì)
|
Atibeprone |
阿替普隆 |
153420-96-3 |
詳細(xì)
|
EOB-DTPA |
釓噻酸 |
158599-72-5 |
詳細(xì)
|
Xanomeline tartrate |
酒石酸沙諾美林 |
152854-19-8 |
詳細(xì)
|
MIV-6R |
4-[3-[4-[(R)-amino-cyclopentyl-phenylmethyl]piperidin-1-yl]propoxy]benzonitrile |
1560968-55-9 |
詳細(xì)
|
c-Fms-IN-10 |
c-Fms-IN-10 |
1527517-50-5 |
詳細(xì)
|
Dectrekumab |
德屈庫(kù)單抗 |
1528523-94-5 |
詳細(xì)
|
Faricimab |
法瑞西單抗 |
1607793-29-2 |
詳細(xì)
|
ASM-024 |
化合物 T26666 |
1609534-88-4 |
詳細(xì)
|
Cadrofloxacin |
鹽酸卡德沙星 |
153808-85-6 |
詳細(xì)
|
Azilsartan mepixetil |
阿齊沙坦雜質(zhì)94 |
1596357-16-2 |
詳細(xì)
|
Cosalane |
cosalane |
154212-56-3 |
詳細(xì)
|
Sabcomeline hydrochloride |
1-Azabicyclo(2.2.2)octane-3-acetonitrile, alpha-(methoxyimino)-, monohydrochloride, (R-(Z))- |
159912-58-0 |
詳細(xì)
|
Ruzasvir |
S 14506HCL |
1613081-64-3 |
詳細(xì)
|
Burosumab |
Burosumab |
1610833-03-8 |
詳細(xì)
|
Risankizumab |
Immunoglobulin G1, anti-(human interleukin 23 subunit p19) (human-Mus musculus heavy chain), disulfide with human-Mus musculus κ-chain, dimer |
1612838-76-2 |
詳細(xì)
|
(Rac)-Zevaquenabant |
(RAC)-ZEVAQUENABANT |
1610420-28-4 |
詳細(xì)
|
Cabiralizumab |
Cabiralizumab |
1613144-80-1 |
詳細(xì)
|
Tamtuvetmab |
Tamtuvetmab |
1608122-71-9 |
詳細(xì)
|
Erenumab |
厄瑞努單抗 |
1582205-90-0 |
詳細(xì)
|